Drugs / Follistim
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | FOLLISTIM | — | 1997-09-29 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT02069808 | Apr 2014 → Feb 2017 | — | Michigan Reproductive Medicine | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT01577199 Comparator | Apr → Dec 2012 | female infertility | Weill Medical College of Cornell University | Withdrawn | No outcome recorded Stop: Enrollment |
| — | NCT01286051 Comparator | Jan 2011 → Sep 2012 | — | Houston Fertility Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Follistim | “225 international units of gonadotropins (eg Follistim , Menopur)” NCT01577199 ↗ |
| Modality | Protein / enzyme biologic | “recombinant FSH (Follistim ™)” NCT02069808 ↗ |